摘要:精神分裂症是一种慢性且严重的精神障碍,其症状簇中具有高异质性。药物治疗对该疾病的有效性远非令人满意。,如果我们旨在了解其遗传/神经生物学机制并找到更有效的治疗方法,那么使用有效动物模型的研究是必不可少的。The present article presents an overview of six genetically-based (selectively-bred) rat models/strains, which exhibit neurobehavioral schizophrenia-relevant features, i.e ., the Apomorphine-susceptible (APO-SUS) rats, the Low-prepulse inhibition rats, the Brattleboro (BRAT) rats, the Spontaneously Hypertensive rats (SHR), the Wisket大鼠和罗马高避免(RHA)大鼠。引人注目的是,所有菌株都表现出脉搏预抑制(PPI)的损害,在大多数情况下,这显着与新颖性诱导的超量化,社会行为的缺陷,潜在抑制和COG-nitive抑制和额叶前五额外的五额外抑制作用或额叶前五额外的Cortex Cortex(PFC)功能有关。However, only three of the strains share PPI deficits and dopaminergic (DAergic) psychostimulant-induced hyperlocomotion (together with prefrontal cortex dysfunction in two models, the APO-SUS and RHA), which points out that alterations of the mesolimbic DAergic circuit are a schizophrenia-linked trait that not all models reproduce, but it characterizes some strains这可能是与精神分裂症相关的特征和药物添加脆弱性的有效模型(因此是双重诊断)。我们通过在研究领域标准(RDOC)框架的背景下将基于这些基于这些遗传选择的大鼠模型的研究结束,这表明使用有选择的培育菌株以RDOC为导向的研究计划可能有助于与SCHIZOPHRENIA相关研究的各个方面的进展有助于与SCHIZOPHIAS相关研究的各个方面的进步。
主要关键词